References
- Daly PA, Schiffer CA, Aisner J, Wiernik PH. Platelet transfusion therapy. One hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA 1980; 243:435–8.
- Sinor LT. Preparation of chloroquine treated platelets to differentiate HLA and non-HLA platelet antibodies on a solid phase red cell adherence assay. Immucorrespondence, 1988.
- Leach MF, AuBuchon JP, Sinor LT. Serologic effects of G-CSF administration during autologous marrow transplant (abstract). Transfusion 1993; 33:78S.
- Leach MF, AuBuchon JP. Effect of storage time on clinical efficacy of single-donor platelet units. Transfusion 1993; 33:661–4.
- Technical manual. Virginia Vengelen-Tyler, ed. 12th ed. Bethesda, MD: American Association of Blood Banks, 1996; 376–7, 646–7.
- Rodney G. Class I antigens: HLA-A, -B, -C and crossreactive groups. In: Moulds JM, Fawcett KJ, Garner RJ, eds. Scientific and technical aspects of the major histocompatibility complex. Arlington, VA: American Association of Blood Banks, 1989:23–46.
- Rodney G. Prevention of alloimmunization in thrombocytopenia patients. In: Smith DM Jr, Summers SH, eds. Platelets. Arlington, VA: American Assoication of Blood Banks, 1988:93–113.
- Garratty, G. In vitro reactions with red blood cells that are not due to blood group antibodies: a review. Immunohematology 1998; 14:49–60.
- Lalezari P, Jiang AF, Kumar M, Lalezari I. Carbohydrate-specific antibodies in normal human sera. I. ß-D-glucose. Vox Sang 1984;47:133–45.
- Martinez C, Muniz-Diaz E, Sola C, et al. Incidence of immune platelet refractoriness in breast cancer patients treated with hematopoietic stem cells transplantation (HSCT) (abstract). Vox Sang 1988; 74:51a.